MBP metabolic pharmaceuticals limited

undervalued and starting to attract attention, page-9

  1. sle
    11,025 Posts.
    lightbulb Created with Sketch. 355
    Yep I followed XCD for years and was disappointed that MBP acquired the 60% holding in PolyNovo but unfortunately for XCD I think it was a case of having to do something otherwise they were out the door. Good opportunity for MBP though. Interesting also the share acquisitions of late for MBP!

    Like I say for those not in the know with this product take the time to have a look at what CSIRO/XCD etc have been up to on the ASX XCD announcements and the XCD website! Well worth investigating IMO.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.